MANAR EDRISS
Allopathic & Osteopathic Physicians|Dermatology OKLAHOMA CITY, OK NPI 1740930619
Browse related groups: Allopathic & Osteopathic Physicians|Dermatology OK Incyte Corporation All categories
General Payments — all program years on this page
$972.56
- Category: General Payments
- Program years: PY2024
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $972.56 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $972.56 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $140.00 | 1 |
| Janssen Scientific Affairs, LLC | $136.36 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $124.99 | 1 |
| UCB, Inc. | $121.18 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $119.78 | 1 |
| Arcutis Biotherapeutics, Inc. | $117.60 | 1 |
| Kyowa Kirin, Inc. | $114.03 | 1 |
| Lilly USA, LLC | $98.62 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $972.56 | 8 |
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078857078 | Janssen Scientific Affairs, LLC | $136.36 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086950037 | Novartis Pharmaceuticals Corporation | $124.99 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118137502 | Boehringer Ingelheim Pharmaceuticals, Inc. | $119.78 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1121061073 | Arcutis Biotherapeutics, Inc. | $117.60 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1127036318 | Kyowa Kirin, Inc. | $114.03 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135154470 | Lilly USA, LLC | $98.62 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141288098 | Incyte Corporation | $140.00 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143252341 | UCB, Inc. | $121.18 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.